RTW Investments, LP
Investment Details
Investor Type
Private Investment Firm
Asset Class Focus
Private Equity, Venture Capital, Hedge Funds
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States, United Kingdom, Germany, China, Switzerland, Spain, Netherlands, Belgium, Israel
Industries Focus
- Healthcare
- Life Sciences
- Healthcare Services
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Oncology
- Neurology
- Endocrinology
- Infectious Diseases
- Immunology
- Cardiovascular
- Ophthalmology
- Respiratory
- Muscular
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2009
RTW Investments, LP is a life sciences investment and innovation firm headquartered in New York, with additional offices in London and Shanghai. The firm specializes in investing across the full lifecycle of companies, including company creation, early-stage venture capital, crossover, and public company investments. RTW focuses on identifying transformative assets with growth potential across the life sciences sector, driven by deep scientific experience and a long-term investment horizon.
The firm's investment strategy encompasses a broad range of stages, from early-stage startups to established public companies. RTW's portfolio includes investments in biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare services. The firm employs a research-driven approach, leveraging proprietary data and expertise across therapeutic areas to spot opportunities others may miss.
RTW Investments is committed to supporting companies that aim to make a significant impact on patient outcomes. The firm's team comprises professionals with backgrounds in healthcare research, finance, and operations, working collaboratively to build successful companies around innovative ideas. RTW's approach is characterized by a combination of scientific expertise, long-term investment perspective, and a focus on value creation and patient impact.
Requirements
- Innovative healthcare solutions
- Strong growth potential
- Experienced management teams
- Commitment to patient impact
- Alignment with RTW's investment strategy
- Strong scientific foundation
- Scalable business models
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Armo Biosciences
- Avidity Biosciences
- Beta Bionics
- CinCor Pharma
- CORXEL
- Encoded
- GH Research
- Orchestra BioMed
- Prometheus Biosciences Inc
- Rocket Pharmaceuticals Inc
- Tarsus
- Tenaya
- Umoja Biopharma
- Ventyx
- Visus
- Yarrow
- Ensoma
- CytomX Therapeutics
- Oruka Therapeutics
Mentioned In
-
$14.95
-
$39.95
-
$24.95
-
$19.95
-
$24.95
-
$99.00
-
$299.00
-
$95.00
Claim this Investor
Are you an official representative of RTW Investments, LP?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim